With a state-of-the-art lab and an advisory committee featuring local employers, the biotechnology program launching this fall at Omaha's Metropolitan Community College aims to equip students to enter ...
Prefer Newsweek on Google to see more of our trusted coverage when you search. In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes ...
5AM Venture Management sold 170,000 shares of Praxis Precision Medicines in the fourth quarter. The quarter-end position value decreased by $9.01 million as a result of the move, which marked a full ...
Superstring Capital Management reduced its stake in Terns by 345,869 shares during the fourth quarter; the estimated trade value was $7.99 million based on quarterly average prices. Meanwhile, the ...
When Gossamer Bio announced poor results from its flagship blood pressure study in February, the San Diego company’s stock dropped by 78% in value. Now, it’s slashing its staff. The biotech lab began ...
METRO COMMUNITY COLLEGE CELEBRATES ITS NEW BIOTECHNOLOGY PROGRAM. IT’S. IT’S LAUNCHING AT THE ELKHORN CAMPUS AS KETV NEWSWATCH 7 SCHUYLER REPORTS, THE GOAL IS TO GET STUDENTS READY FOR A RAPIDLY ...
Damian Garde is a reporter at large, live and feature journalism, covering the global drug industry and contributing to STAT’s industry-leading events. Boris Nikolic’s career looked to be in tatters.
CARVYKTI ® (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $555 million and $1.9 billion for the fourth quarter and full year 2025, respectively Surpassed milestone of more ...
A controversial political appointee at the Food and Drug Administration plans to step down for a second time, and the biotech company at the center of a recent debate that involved him saw its stock ...
ISC Class 12 Biology Exam 2026 was conducted on 6 March 2026 from 2:00 PM to 5:00 PM by the Council for the Indian School Certificate Examinations (CISCE). Biology is an important subject for Class 12 ...
Nvidia (NVDA) and Eli Lilly (LLY, down 7% YTD, forward P/E under 30x) in $1B partnership. Eli Lilly deploys AI for drug discovery via Nvidia partnership and LillyPod supercomputer as biotech provides ...
Shared 12-month clinical results of ongoing UP421 type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplanted without immunosuppression are safe and well-tolerated, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results